Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment
about
Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer diseaseThe Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriersUshering in the study and treatment of preclinical Alzheimer diseaseFollow-up evaluation of cognitive function in the randomized Alzheimer's Disease Anti-inflammatory Prevention Trial and its Follow-up StudyRecognition of famous names predicts cognitive decline in healthy eldersClinical-pathologic study of depressive symptoms and cognitive decline in old ageSynaptic plasticity in sleep: learning, homeostasis and diseaseEarly life instruction in foreign language and music and incidence of mild cognitive impairment.Attempted and successful compensation in preclinical and early manifest neurodegeneration - a review of task FMRI studiesThe independent contributions of cognitive impairment and neuropsychiatric symptoms to everyday function in older adults.Longitudinal change in working memory as a function of APOE genotype in midlife and old age.Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer's disease.Trajectories of dementia-related cognitive decline in a large mental health records derived patient cohortA classification algorithm for predicting progression from normal cognition to mild cognitive impairment across five cohorts: The preclinical AD consortium.How Does Psychosocial Behavior Contribute to Cognitive Health in Old Age?Everyday episodic memory in amnestic mild cognitive impairment: a preliminary investigation.Gray and white matter changes in subjective cognitive impairment, amnestic mild cognitive impairment and Alzheimer's disease: a voxel-based analysis studyCognitive changes preceding clinical symptom onset of mild cognitive impairment and relationship to ApoE genotype.Comparing measures of decline to dementia in amnestic MCI subjects in the National Alzheimer's Coordinating Center (NACC) Uniform Data SetAn empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease.Interaction of transactive response DNA binding protein 43 with nuclear factor κB in mild cognitive impairment with episodic memory deficits.The relationship between midlife and late life alcohol consumption, APOE e4 and the decline in learning and memory among older adults.Lewy bodies and olfactory dysfunction in old ageBrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer's Disease.Conscientiousness, dementia related pathology, and trajectories of cognitive agingDementia and Alzheimer's disease: a new direction.The 2010 Jay L. Foster Memorial Lecture.Brain aging, Alzheimer's disease, and mitochondria.Midlife mental distress and risk for dementia up to 27 years later: the Nord-Trøndelag Health Study (HUNT) in linkage with a dementia registry in NorwayAPOE-ε4 Allele Altered the Rest-Stimulus Interactions in Healthy Middle-Aged Adults.Epitope Fingerprinting for Recognition of the Polyclonal Serum Autoantibodies of Alzheimer's Disease.The Influence of Vascular Risk Factors and Stroke on Cognition in Late Life: Analysis of the NACC Cohort.Comparison of four verbal memory tests for the diagnosis and predictive value of mild cognitive impairmentShort-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease.Cognitive impairment 18 years before clinical diagnosis of Alzheimer disease dementia.The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's DiseaseAppraisal of cognition in preclinical Alzheimer's disease: a conceptual review.Overview and findings from the religious orders studyOverview and findings from the rush Memory and Aging ProjectBraak staging, plaque pathology, and APOE status in elderly persons without cognitive impairmentThe natural history of cognitive decline in Alzheimer's disease.
P2860
Q24634907-6C89AEF7-0465-453A-A2D0-FC81C62C2600Q26849380-F05C9E8F-3A30-47E6-ABB5-BF138AC345CFQ27014791-399AB298-519C-4F6E-94C2-92F4FE04C0ECQ27310286-7EF9F15D-4374-42BA-97D8-2DF7289B484FQ28389799-D316A1AA-8122-4EED-9952-26434B0EC25DQ28393370-4DA29A40-93D4-4E4E-BCB0-ED277F6558C4Q28727857-64F58BE4-40A2-4866-BFFF-E8326E94E43AQ30365567-D87F40B6-3B17-4AE4-BDE5-DBFD45538AA6Q30862037-06A91B49-1A4C-4CD3-92EC-06D74EB7BA7AQ33614473-A227E3D5-851B-4582-8AF0-122697BE7F97Q33719330-5E7EC022-1B89-46D8-B278-8653F33B7BB1Q33745617-8693D092-D23A-416A-85EB-73F35DD9944BQ33773036-A78D0EF5-DF30-459C-9A98-0FC6A3FEC54AQ33813921-B4EBECA1-E464-48BF-A302-BF98CCE58A59Q33831749-C7B930D7-5C7F-4D7D-AC69-1DB2C4B7FF64Q33982038-B451BD34-176F-443E-B395-CBC3F816C168Q34005078-6D84EBD2-744C-475A-B72A-A9F2301E834DQ34180413-C3287EBA-49F1-4964-A315-65288C2983A1Q34311058-92184593-951D-4954-8F6F-0427BAD1BE47Q34364368-7887BC1E-6B20-442C-8AC9-7869F7B81D72Q34504310-39191942-4B4A-4086-9657-D8AB67B87C2DQ34656168-A1CC8A56-88E3-471D-9ED1-F74365553C78Q34776843-1AD51F86-65C7-4844-B013-E9CBF84A9176Q34797000-3057044C-A192-4E99-8632-66B99A0AA582Q35181136-31786359-4624-4ED0-9EE1-DC68F23D4FBAQ35394390-B6F3244F-893A-4300-948A-EBD1F1C9FAB5Q35533354-1B5B018C-DDCD-4B7A-9F7C-BCD765D8DCF7Q35606922-45D2E260-A544-48C1-9146-C8545740CD65Q35656722-B0B48BD8-F5A4-45E1-8A68-0E414138FB34Q35791399-45CC709E-671F-4D63-8484-253D8487DD4AQ35888120-4CE7CCCF-E2CE-400A-BC9C-A93F4CF85A86Q35945383-67C150BC-3AF2-4373-AD6B-B528E4555204Q35948528-BE474ACB-56D4-418B-9C74-C4D326F82C7BQ36027882-AD6E26B3-1E68-4152-9626-23ECCF0C445CQ36075642-541FF71D-225D-4F5D-A043-328609AA7C5CQ36090201-0719890D-E8D9-4B05-AAAE-FD106BDB300DQ36130996-72A4A8FE-6821-4E5A-B3C2-E0BDB2B55B37Q36226167-8816F1E8-4C73-4AB1-A9D0-903E43E7504BQ36393028-D567059A-15A9-4954-BC72-7D8F54DE75C4Q36501426-139285D0-D405-4DA3-BFAD-4BCE703E51AB
P2860
Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment
@ast
Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment
@en
type
label
Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment
@ast
Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment
@en
prefLabel
Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment
@ast
Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment
@en
P2860
P1433
P1476
Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment
@en
P2093
Patricia A Boyle
Robert S Wilson
P2860
P304
P356
10.1001/ARCHNEUROL.2011.31
P577
2011-03-01T00:00:00Z